The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special ...

Ms. Wojcicki’s proposal, which was included in an amended Schedule 13D filing made by Ms. Wojcicki with the Securities and ...

Me’s special committee of independent directors on Monday rejected CEO Anne Wojcicki’s proposal to take the distressed ...

The special committee of the board of directors of 23andMe (ME) confirmed receipt of a non-binding proposal from Anne Wojcicki, CEO, ...

Anne Wojcicki ... $0.41 per share. Ms. Wojcicki’s proposal, which was included in an amended Schedule 13D filing made by Ms. Wojcicki with the Securities and Exchange Commission earlier today ...

23andMe's special committee of independent directors on Monday rejected CEO Anne Wojcicki's proposal ... according to a filing with the U.S. Securities and Exchange Commission.

23andMe's special committee of independent directors on Monday rejected CEO Anne Wojcicki's proposal ... to a filing with the U.S. Securities and Exchange Commission. The stock plunged 33% on ...

The Special Committee of the Board of Directors of 23andMe Holding Co. ("23andMe" or the "Company") (Nasdaq: ME) today confirmed receipt of a non-binding ...

The Special Committee of the Board of Directors of 23andMe Holding Co. (NASDAQ:ME) today announced its unanimous decision to reject a buyout offer from Anne ... Wojcicki was disclosed in an amended ...

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags ...